Vaccine: Clinical Trials

3 trials for Vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19
Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for intramuscular injection - Coronavirus Infections, Vaccine
Phase 1 / Phase 2CompletedChumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products4002020-10-032021-11-12
Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine
cH8/1N1 LAIV, AS03-adjuvanted cH5/1N1 IIV, cH5/1N1 IIV - Influenza, Vaccine
Phase 1CompletedPATH652017-10-102021-02-21
Open-label Safety and Tolerability Study of CoVaccine HTâ„¢ in Healthy Volunteers
CoVaccine HT - Vaccine
Phase 1CompletedBTG International Inc.502009-11-012014-09-15

Narrower conditions

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Hypertension (1)  ·  Influenza, Human (1)

Broader conditions

Infections (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Orthomyxoviridae Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Vascular Diseases (1)

Interventions

AS03 adjuvant (1)  ·  Injections, Intramuscular (1)  ·  Saline Solution (1)  ·  Vaccines (1)

Sponsors

BTG International Inc. (1)  ·  Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products (1)  ·  PATH (1)

Countries

Russia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Darren Wilbraham, MB., BS (1)  ·  David Bernstein, MD (1)  ·  Jeffrey Guptill, MD (1)

Results publications

PMID 31630990, PMID 33288923, PMID 36533948, PMID 40132593